However, with IL-2/IL-15IL-21 conditioning, there appeared to be a dramatic increase, in mesothelin reactivity suggesting that there are indicating that there are circulating mesothelin-specific T cells in peripheral blood of individuals who are cancer-/tumor-free, although these anti-mesothelin - reactive T-cells are below detection levels. This evidence concerns the gene MSLN and cancer.